Key result
Higher TyG index is linked to increased femoral, but not carotid, plaques in CKD.
Why the study?
Does a higher triglyceride-glucose (TyG) index increase the burden of femoral and carotid atherosclerosis in patients with chronic kidney disease?
Observational (n=2,099)
Does a higher triglyceride-glucose (TyG) index increase the burden of femoral and carotid atherosclerosis in patients with chronic kidney disease?
Answers are grounded in this paper and cite their sources.
A higher triglyceride-glucose index is causally associated with an increased burden of subclinical femoral atherosclerosis in patients with chronic kidney disease.
OBJECTIVE: Patients with chronic kidney disease (CKD) have a higher risk of cardiovascular events than matched non-CKD individuals. The triglyceride-glucose (TyG) index is a calculated metric used to predict cardiometabolic risk. Although TyG is associated with cardiovascular events in CKD, its relationship with atherosclerotic burden remains unexplored. This study aimed to investigate this association using Mendelian randomization (MR) METHODS: Subjects from the NEFRONA study with ultrasound assessment of atherosclerotic plaque presence in 6 carotid and 4 femoral arterial territories were included. Multivariable linear regression models were used to explore the association between TyG index and atherosclerotic burden. Two-sample MR was employed to assess whether the TyG index has a causal effect on the number of carotid and femoral plaques. RESULTS: 358 controls, 709 CKD G3, 569 CKD G4-5 and 463 dialysis subjects were included. Higher TyG levels, analyzed as a continuous variable or by quartiles, were positively associated with the number of plaques in both territories. After multivariable adjustment, the association with femoral plaques remained statistically significant both as a linear variable (beta = 0.11; P = .02) and by quartiles (Q3 vs Q1: beta = 0.16; P = .026; Q4 vs Q1: beta = 0.17; P = .026; Tendency analysis: beta = 0.06; P = .02). Several unadjusted MR methods showed an effect of genetic variants associated with higher TyG levels on femoral, but not carotid, atherosclerosis. Multivariable inverse-variance weighted analysis adjusted for multiple variables suggested a causal relationship between higher TyG index and the number of femoral plaques (estimate:0.95; 95% confidence interval: 0.1-1.80, P = .029). CONCLUSIONS: Our two-sample MR study suggests a causal effect of higher TyG index on subclinical atherosclerotic burden in femoral arteries in CKD. Genetic testing could be used to stratify the risk of lower-limb atherosclerosis in CKD patients.
No takes yet. Share an insight, caveat, or question.
Cambray et al. (2026) conducted an observational in Chronic kidney disease (n=2,099). Higher triglyceride-glucose (TyG) index vs. Lower TyG index was evaluated on Number of femoral plaques (estimate 0.95, 95% CI 0.1-1.80, p=0.029). Higher triglyceride-glucose index was causally associated with increased femoral, but not carotid, plaques in chronic kidney disease patients.
Synapse has enriched 10 related papers. Consider them for comparative context: